Orit Freedman

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Matthew P. Goetz, Masakazu Toi, Mario Campone et al. · Journal of Clinical Oncology · 2017 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · JAMA Oncology · 2021 · 349 citations · Full text

Medicine, Oncology, Pharmacology +17

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3

M.P. Goetz, M. Toi, Jens Huober et al. · Annals of Oncology · 2024 · 206 citations · Full text

Medicine, Oncology, Pharmacology +16

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies

Eitan Amir, Mark Clemons, Colin A. Purdie et al. · Cancer Treatment Reviews · 2011 · 175 citations

Medicine, Oncology, Pathology +12

Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing

Swati Garg, Teddy S. Nagaria, Blaise Clarke et al. · Modern Pathology · 2019 · 87 citations · Full text

Medicine, Molecular Biology, Oncology +14